Adocia - Company & Market Research Reports

Adocia is a biotechnology company which focuses on producing treatments for diabetes. It was founded in 2005, and headquartered in Lyon, France. The Company develops a BioChaperone Platform used for therapeutic protein delivery in regenerative medicine and chronic disease areas. There pipeline of products include: Biochaperone Lispro, Biochaperone Combo, Hinsbet, Biochaperone Human Glucagon, Biochaperone Glargine GLP-1, Biochaperone Prandial combinations for T1D.

From
From
From
From
From
From
Type 2 Diabetes - Pipeline Review, H1 2018 - Product Thumbnail Image

Type 2 Diabetes - Pipeline Review, H1 2018

  • Drug Pipelines
  • 1109 Pages
From
From
From
Type 2 Diabetes - Pipeline Review, H2 2017 - Product Thumbnail Image

Type 2 Diabetes - Pipeline Review, H2 2017

  • Drug Pipelines
  • 1126 Pages
From
From
From
Hypoglycemia - Pipeline Review, H2 2018 - Product Thumbnail Image

Hypoglycemia - Pipeline Review, H2 2018

  • Drug Pipelines
  • 78 Pages
From
From
From
From
Loading Indicator
adroll